As TR4 may play roles in the PCa DTX resistance [20], we also retrospectively investigated the TR4 expression through immunohistochemical (IHC) staining of clinical samples from metastatic PCa patients treated with DTX chemotherapy. This evidence concerns the gene NR2C2 and posterior cortical atrophy.